Roche
ROG.SW
$242.78
Share price
-3.35%
Change (1 day)
-22.89%
Change (1 year)
Categories
P/S ratio for Roche (ROG.SW)
P/S ratio at the end of 2023: 3.26
According to Roche's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.8244. At the end of 2023 the company had a P/S ratio of 3.26.
P/S ratio history for Roche from 2006 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.26 | -10.64% |
| 2022 | 3.64 | -30.37% |
| 2021 | 5.23 | 15.69% |
| 2020 | 4.52 | 3.85% |
| 2019 | 4.35 | 19.49% |
| 2018 | 3.64 | -7.15% |
| 2017 | 3.93 | -0.43% |
| 2016 | 3.94 | -19.42% |
| 2015 | 4.89 | 1.4% |
| 2014 | 4.82 | 6.83% |
| 2013 | 4.52 | -28.62% |
| 2012 | 6.33 | 94.73% |
| 2011 | 3.25 | 29.52% |
| 2010 | 2.51 | -20.06% |
| 2009 | 3.14 | 1.44% |
| 2008 | 3.09 | -16.77% |
| 2007 | 3.72 | -16.87% |
| 2006 | 4.47 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.87 | 37.18% | 🇺🇸 USA |
 Novartis NVS | 3.93 | 39.12% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.55 | -9.79% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.65 | 64.80% | 🇺🇸 USA |
 Amgen AMGN | 5.20 | 84.28% | 🇺🇸 USA |
 Sanofi SNY | 2.36 | -16.30% | 🇫🇷 France |
 Becton Dickinson BDX | 3.47 | 22.98% | 🇺🇸 USA |
 Merck MRK | 5.35 | 89.29% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.23 | -21.18% | 🇬🇧 UK |